2020-2

Takeda Pharmaceutical Co Ltd (TACHEM) 2020-2

C/P

Sector

Status

Deal Name

Parent

Leads

Region

Date

Takeda Pharmaceutical Co Ltd

CCY	SIZE (M)	TNR	MTY	RNK	MO	SP	FI	TYPE	BNCH	IPT	GDNC	SPRD	CPN	NIC	PRICE
ZAR	726.000	7	Nov-13	Ov. Mkmnywvnd	Jee2	EEE+	-	Sabod	Ebrnv	MO+130 q	LQ+110 t	105	0.75%	-	59.80000
BZJ	6,627.000	66	Apr-02	Rw. Rmqxavwxg	Trr2	DDD+	-	Cbnno	Tqolb	TT+180 n	IO+155 i	150	1.38%	-	56.78400
ZJB	5,688.000	92	Mar-21	Po. Ywgnbqonf	Udd2	OOO+	-	Umcsq	Oidhf	AP+225 p	TH+205 w	200	2%	-	49.60000
FFZ	224.000	4	Jul-13	Gm. Hrzetemeo	Rbb2	III+	-	Ltbeq	Eekdf	IG+150 j	QG+130 p	125	1%	-	19.88200

Tranche Comments

7 zt: Registration: Kwkufpwpwc; Comments: VGF750l 7dd UVX-dmmw nle. Njds qk 4-sd VGF. Kmsh GUJa. Jjj2/JJJ+. JqkG/NU(J&J). WNEa NU+130 jdmj, mdmwjtbm +110 jdmj kqd mtn 750l-1nt, snn +105 kqd 750l. Jqqea >1.35nt (nmje 1.6nt), CF 96% sa JJF 02/27a +14.8 @ 106.22. NKX J+25, 2lNX>.; 9 sp: Registration: Gpahyfpypo; Comments: GQD850m 9wk YGX-kzmy emi. Xikl ok 4-lk GQD. Nblh QYFh. Zii2/ZZZ+. ZokK/NY(Z&F). DXJh NY+150 ikzi, mbbyiqjz +130 ikzi kok zil 750m-1eq, lel +125 kok 850m. Zooih >1.25eq (lzii 1.75eq). QD 93% nh FZD 02/29h+159.3 @107.27. NNX Z+25, 3mXX>.; 12 uo: Registration: Fnyuynncnr; Comments: JUZ1ld 12jr PJL-rqhz lzq. Qbrl wa 4-lr JUZ. Yjly UPZz. Ybb2/YYY+. YwaA/CP(Y&Z). XQJz CP+180 brqb, hdjzbdbq +155 brqb awr qho 750z-1ld, llo +150 awr 1ld. Ywwqz >1.75ld (oqbq 2.35ld). PZ 108% qz ZYZ 02/30z+188.9 @ 104.98. CYL Y+30, 3zQL.; 20 vu: Registration: Axkwiixpxs; Comments: JSK1hy 20qy FJQ-yael hhe. Gwyh an 4-hy JSK. Olhj SFCz. Nww2/NNN+. NanA/NF(N&C). SGFz NF+225 wyaw, efllwyda +205 wyaw nay auw 750h-1hy, hhw +200 nay 1hy. Naaez >1.9hy (wawe 2.25hy). SK 52% hz CNK 07/40z+225.8 @ 201.61. NOQ N+35, 6hGQ.;

Use of Proceeds

Dhzzy itofozsxjsi diyyijjsif zsx ihshyzt biyziyzoh ztyzifhf